Tendyne™ TMVR System is first-in-class technology designed to eliminate mitral regurgitation (MR), offering select patients with MR (≥ grade 3), a novel option for mitral valve replacement.
Tendyne™ TMVR System is first-in-class technology designed to eliminate mitral regurgitation (MR), offering select patients with MR (≥ grade 3), a novel option for mitral valve replacement. Tendyne TMVR provides symptom relief by eliminating MR.
– Beating heart procedure without the need for cardiopulmonary bypass or rapid pacing;
– Complete MR elimination in 99% of patients at 30 days;
– Sustained MR elimination in 93% of patients at 2 years;
– 96% technical success rate;
– System is fully repositionable and retrievable at any point intraprocedurally;
– Significant improvement in symptom and quality-of-life measures;
– Low mean mitral gradient of 3.2 mm Hg at 2 years;
The duration of a percutaneous mitral valve prosthesis surgery is normally 120 minutes. Patients are discharged after 1-2 days.
Regarding work activity, after XX days the patient will be able to return to work. Normally, full mobility recovery is at the end of XX and moderate physical activity at XX.
The duration of a percutaneous mitral valve prosthesis surgery is normally 120 minutes. Patients are discharged after 1-2 days.
Regarding work activity, after XX days the patient will be able to return to work. Normally, full mobility recovery is at the end of XX and moderate physical activity at XX.
Time
› 120 min
Anesthesia
› General
Internment
› 1-2 days
Sick leave
› 1 week
Recovery
› 1 week
Inhibition of physical activity
2 weeks
See more
about this
procedure
Make an appointment to clarify any doubts or call us through our contacts